Abstracts (HTML) List of Authors

Abbas, T

Metabolic reprogramming in livers of mice with chronic liver disease

Abdelaziz, AI

Strategies to identify oncogene-dependent long non-coding RNAs (lncRNAs) in liver cancer

Abdelrahim, EA

Metabolic reprogramming in livers of mice with chronic liver disease

Abdullah, Z

A dual role for hepatocyte-intrinsic canonical NF-κB signaling in virus control

Abu-Omar, J

Low muscle mass and large portosystemic shunt in “one-stop shop” CT exponentially increases risk for HE and mortality

Adamek, E

Evaluation of a piglet model for Parenteral Nutrition-associated Cholestasis (PNAC)

Addo, M

Vergleich der Hepatitis E Seroprävalenz und Virämie zwischen HIV- und Transplant-Patienten

Adenugba, A

Lipid-loaded Hepatocytes fail to Suppress IL-4 Production by Human CD4+ iNKT Cells
In-vitro Activation and anti-viral Function of Innate NK cells in HEV Infection

Ahlbrand, CJ

Epidemiologie und Auswirkungen bakterieller Infektionen bei stationären Patienten mit Leberzirrhose
Symptom burden and treatment response in patients with primary biliary cholangitis (PBC)
Extrakorporale Leberunterstützung mit ADVOS in Patienten mit ACLV und HRS – Erste Ergebnisse einer Single Center Studie
Non-malignant portal vein thrombosis in liver cirrhosis – predictors of risk and the use of anticoagulation

Ahmed, YA

Metabolic reprogramming in livers of mice with chronic liver disease

Ahrenstorf, AE

Single cell RNA sequencing reveals naïve T cells ready for effector function in livers of Primary Sclerosing Cholangitis

Albrecht, J

M30 als Biomarker für die nicht-invasive NAFLD-Diagnostik bei Patienten mit morbider Adipositas nach Roux-y-Magenbypass

Albrecht, M

HER2 amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis

Albrrecht, T

HER2 amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesis

Alex, S

Smad3 linker (S213 and S204) phosphorylation as indicators for the prediction of cholangiocarcinoma outcome

Alexandrov, A

Safety and Efficacy of 10 mg Myrcludex B/IFNa Combination Therapy in Patients with Chronic HBV/HDV Co-Infection

Ali, A

Antioxidant-based therapy in non-alcoholic steatohepatitis (NASH) and NASH-induced hepatocellular carcinoma development

Alizor, H

Deletion of Sirtuin 6 affects tumor-directed innate immune responses in a syngeneic mouse model of hepatocellular carcinoma

Allweiss, L

Both interferon and siRNA treatments promote reappearance of SMC5/6 complex but have different impact on cccDNA
Safety and Efficacy of 10 mg Myrcludex B/IFNa Combination Therapy in Patients with Chronic HBV/HDV Co-Infection

Alonso-Peña, M

Suppression of bile acid-CoA:amino acid N-acyltransferase gene expression by Oncostatin M

Altfeld, M

Single cell RNA sequencing reveals naïve T cells ready for effector function in livers of Primary Sclerosing Cholangitis

Ambrosy, L

Alteration of the gut microbiota in patients with primary sclerosing cholangitis and concomitant dominant strictures

Amit, I

Adverse effects of PD-1 targeted immunotherapy in NAFLD-triggered HCC

Andersen, JB

KRAS-mutated intrahepatic cholangiocarcinoma shows preferential sensitivity towards PARP-1-based interventions

Angel, P

RAGE signaling in liver progenitor cells affects fibrosis upon liver injury

Ansgar, L

Autoaggression of FOXO1lowCXCR6hiCD8+ T cells causing liver pathology in NASH

Anstee, QM

Adverse effects of PD-1 targeted immunotherapy in NAFLD-triggered HCC

Appel, S

Maternal exercise conveys protection against NAFLD in the offspring via hepatic metabolic programming

Aprupe, L

Mathematical modeling of the YAP/TAZ shuttling as a response to cell density, actin dynamics, and liver damaging drugs

Arezu Saberi, V

Augmenter of Liver Regeneration (ALR) reduziert die Gallensäure induzierte Apoptose

Arneth, B

M30 als Biomarker für die nicht-invasive NAFLD-Diagnostik bei Patienten mit morbider Adipositas nach Roux-y-Magenbypass

Arola, J

Genomic characterization of cholangiocarcinoma in primary sclerosing cholangitis reveals novel therapeutic opportunities

Arslanow, A

Europäische Studie: Heterozygoter Alpha-1-Antitrypsinmangel (Pi*MZ) führt zu einem intermediären Leber-Phänotyp
Metabolische Veränderungen bei Erwachsenen mit homozygotem Alpha1-Antitrypsinmangel (Pi*ZZ Genotyp)
SEAL program – Early detection of liver fibrosis and cirrhosis by screening of the general population

Asawa, S

Human 3-dimensional liver organoids: in vitro model systems to study liver diseases

Aschenbrenner, E

Induction of apoptosis in hepatocellular carcinoma by a novel combination of histone deacetylase inhibitor LBH589

Asensio, I

Shedding light on BASH: A novel experimental model of advanced liver damage